141 Comparison of overall survival (OS) in metastatic non-small cell lung cancer (mNSCLC) patients treated with pembrolizumab monotherapy between NHS Tayside and KEYNOTE-024

Lung Cancer 2026

View at publisher

Authors: Ting Feng Ho, Ee Qing Thee, Hannah Lord

DOI: 10.1016/j.lungcan.2026.109090

Cited by: 0

References: 2

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Lung Cancer Diagnosis and Treatment

References 2